SIRT1 and Peritoneal Fibrosis: Furthermore, the same group reported that human umbilical cord mesenchymal stem cells (hUCMSCs) overexpressing SIRT1 display therapeutic potential in peritoneal fibrosis, as administration of SIRT1-modified hUCMSCs enhanced antifibrotic efficacy, inhibited EMT, and improved ultrafiltration [23].